Invesco Ltd. Novavax Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Invesco Ltd. holds 905,167 shares of NVAX stock, worth $8.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

905,167

Previous 154,969 484.1%

Holding current value

$8.44 Million

Previous $1.96 Million 482.97%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.71 - $17.11 $8.03 Million - $12.8 Million	750,198 Added 484.1%	905,167 $11.4 Million
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $16,645 - $89,730	4,279 Added 2.84%	154,969 $1.96 Million
Q1 2024 May 14, 2024	BUY	$3.76 - $6.02 $443,070 - $709,384	117,838 Added 358.69%	150,690 $720,000
Q4 2023 Feb 12, 2024	SELL	$4.8 - $7.67 $8,721 - $13,936	-1,817 Reduced 5.24%	32,852 $157,000
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $5,945 - $8,503	-873 Reduced 2.46%	34,669 $251,000
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $540,456 - $771,386	-81,028 Reduced 69.51%	35,542 $264,000
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $231,102 - $500,722	40,122 Added 52.48%	116,570 $807,000
Q4 2022 Feb 13, 2023	SELL	$8.86 - $25.04 $369,355 - $1.04 Million	-41,688 Reduced 35.29%	76,448 $785,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $73,473 - $307,296	4,037 Added 3.54%	118,136 $2.15 Million
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $275,220 - $571,149	-7,586 Reduced 6.23%	114,099 $5.87 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $3.82 Million - $7.83 Million	-54,772 Reduced 31.04%	121,685 $8.96 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $15.6 Million - $25.2 Million	115,761 Added 190.72%	176,457 $25.2 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $1.78 Million - $2.71 Million	10,034 Added 19.81%	60,696 $12.6 Million
Q2 2021 Aug 17, 2021	SELL	$121.0 - $257.67 $8.09 Million - $17.2 Million	-66,869 Reduced 56.89%	50,662 $10.8 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $2.59 Million - $7.33 Million	-22,897 Reduced 16.31%	117,531 $21.3 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $2.34 Million - $4.14 Million	-29,709 Reduced 17.46%	140,428 $15.7 Million
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $18.2 Million - $40.9 Million	-228,990 Reduced 57.37%	170,137 $18.4 Million
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $1.71 Million - $10.3 Million	-123,498 Reduced 23.63%	399,127 $33.3 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $2.05 Million - $8.36 Million	522,625 New	522,625 $7.1 Million

Others Institutions Holding NVAX

# of Institutions

289

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $729M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account